Elevance Health, Inc. - Common Stock (ELV) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ELV on NYSE
Shares outstanding
225,970,109
Price per share
$350.55
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
195,579,553
Total reported value
$63,211,314,327
% of total 13F portfolios
0.06%
Share change
-9,018,011
Value change
-$3,318,811,142
Number of holders
1,490
Price from insider filings
$350.55
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elevance Health, Inc. - Common Stock (ELV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $9,973,051,545 22,890,772 The Vanguard Group 30 Apr 2025
BlackRock, Inc. 7.8% $7,709,208,597 17,694,658 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 1,490 institutional investors reported holding 195,579,553 shares of Elevance Health, Inc. - Common Stock (ELV). This represents 87% of the company’s total 225,970,109 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Elevance Health, Inc. - Common Stock (ELV) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 22,998,645 +0.62% 0.11% $7,431,322,172
BlackRock, Inc. 9.1% 20,533,269 +0.59% 0.12% $6,634,710,108
STATE STREET CORP 4.6% 10,346,169 -2.1% 0.12% $3,343,054,127
WELLINGTON MANAGEMENT GROUP LLP 2.9% 6,621,297 +4.8% 0.37% $2,139,473,488
PRICE T ROWE ASSOCIATES INC /MD/ 2.6% 5,838,911 -28% 0.2% $1,886,670,000
Sanders Capital, LLC 2.6% 5,768,918 -0.97% 2.3% $1,864,052,784
GEODE CAPITAL MANAGEMENT, LLC 2.3% 5,143,904 +0.98% 0.11% $1,661,179,878
Artisan Partners Limited Partnership 2% 4,576,805 +25% 2.1% $1,478,857,232
First Eagle Investment Management, LLC 1.8% 3,998,603 +25% 2.4% $1,292,028,537
HARRIS ASSOCIATES L P 1.4% 3,189,624 +39% 1.7% $1,030,631,439
Capital International Investors 1.3% 2,954,717 -54% 0.15% $954,566,722
MORGAN STANLEY 1.2% 2,683,650 -12% 0.05% $867,142,353
Invesco Ltd. 1.1% 2,597,488 +23% 0.13% $839,300,364
BANK OF AMERICA CORP /DE/ 1.1% 2,595,732 +19% 0.06% $838,732,984
Grantham, Mayo, Van Otterloo & Co. LLC 1.1% 2,523,450 +24% 2.3% $815,377,419
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.1% 2,440,630 +4.8% 0.24% $788,616,366
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.1% 2,386,059 -20% 0.17% $770,983,385
NORTHERN TRUST CORP 1% 2,277,649 -2.1% 0.09% $735,953,944
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.98% 2,213,870 +6.6% 0.59% $715,345,658
BAILLIE GIFFORD & CO 0.96% 2,166,914 -3.1% 0.52% $700,173,251
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.91% 2,045,480 +44% 2% $660,935,498
Nuveen, LLC 0.86% 1,948,118 +2% 0.17% $629,475,795
Legal & General Group Plc 0.85% 1,921,353 +4.8% 0.14% $620,827,581
Brave Warrior Advisors, LLC 0.81% 1,834,002 +65% 14% $592,602,726
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.75% 1,686,220 -6.6% 0.09% $544,851,406

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,953,531 $2,088,430,673 -$24,843,970 $350.55 273
2025 Q3 195,579,553 $63,211,314,327 -$3,318,811,142 $323.12 1,490
2025 Q2 204,604,844 $79,498,363,022 +$1,439,627,484 $388.96 1,568
2025 Q1 200,116,298 $87,037,583,628 -$2,174,451,721 $434.96 1,632
2024 Q4 205,112,458 $75,695,445,812 +$810,431,508 $368.90 1,563
2024 Q3 201,181,768 $104,467,369,419 -$3,937,874,579 $520.00 1,668
2024 Q2 207,495,339 $112,369,341,196 +$2,685,986,911 $541.86 1,686
2024 Q1 203,356,241 $105,423,256,470 -$2,503,098,315 $518.54 1,647
2023 Q4 1,815,450 $855,916,360 -$12,058,288 $471.56 23
2023 Q3 204,882,485 $89,264,985,625 -$735,459,277 $435.42 1,495
2023 Q2 204,318,397 $90,784,164,128 -$2,610,836,696 $444.29 1,490
2023 Q1 209,279,424 $96,261,598,851 -$1,139,823,807 $459.81 1,483
2022 Q4 209,375,128 $107,325,603,950 -$237,468,739 $512.97 1,512
2022 Q3 212,694,705 $96,682,418,582 -$138,940,262 $454.24 1,402
2022 Q2 213,199,938 $102,775,746,647 -$36,977,206 $482.58 1,410
2022 Q1 214,195,148 $105,236,080,897 +$448,573,752 $491.22 1,388
2021 Q4 213,511,316 $98,942,388,592 -$677,583,343 $463.54 1,346
2021 Q3 214,670,881 $80,071,579,982 -$362,749,539 $372.80 1,194
2021 Q2 216,003,328 $82,439,264,564 -$232,130,389 $381.80 1,207
2021 Q1 209,892,429 $75,331,604,640 +$617,129,186 $358.95 1,184
2020 Q4 203,714,575 $65,376,150,700 -$1,301,195,378 $321.09 1,141
2020 Q3 221,550,780 $59,463,819,033 -$836,733,730 $268.59 1,061
2020 Q2 216,168,104 $56,803,016,104 +$598,346,731 $262.98 1,076
2020 Q1 219,433,246 $49,820,887,386 -$352,999,081 $227.04 1,010
2019 Q4 222,378,875 $67,148,795,944 -$902,497,246 $302.03 1,082
2019 Q3 222,814,758 $53,466,546,802 -$531,304,822 $240.10 989
2019 Q2 227,524,063 $64,143,925,072 +$2,251,301,256 $282.21 1,005
2019 Q1 226,279,709 $64,870,591,447 -$546,117,199 $286.98 1,050
2018 Q4 228,394,660 $59,929,365,300 +$654,575,156 $262.63 972
2018 Q3 224,803,116 $61,540,815,771 -$53,838,993 $274.05 927
2018 Q2 227,774,701 $54,159,125,676 +$1,045,205,815 $238.03 908
2018 Q1 226,079,596 $49,599,917,833 +$121,818,394 $219.70 907
2017 Q4 225,993,170 $50,779,887,503 -$172,653,410 $225.01 895
2017 Q3 226,672,720 $43,040,923,480 -$966,087,382 $189.88 832
2017 Q2 234,573,685 $44,155,602,009 -$694,664,198 $188.13 838
2017 Q1 236,468,473 $39,120,962,498 +$4,033,301,639 $165.38 778
2016 Q4 236,010,604 $33,930,499,551 +$285,289,951 $143.77 765
2016 Q3 233,428,186 $29,235,221,249 -$467,029,910 $125.31 715
2016 Q2 237,197,665 $31,152,895,270 +$194,931,134 $131.34 740
2016 Q1 235,507,825 $32,727,572,567 -$91,787,674 $138.99 754
2015 Q4 236,431,112 $32,972,757,121 +$259,918,804 $139.44 749
2015 Q3 233,818,826 $32,732,009,259 +$1,115,587,831 $140.00 748
2015 Q2 224,249,855 $36,802,807,830 -$934,131,792 $164.14 766
2015 Q1 232,550,330 $35,894,190,887 -$122,356,059 $154.41 737
2014 Q4 234,606,877 $29,496,113,731 +$29,318,605,136 $125.67 694
2014 Q3 60,821 $7,275,000 $0 $119.61 1
2014 Q2 60,821 $6,544,000 +$615,978 $107.59 1
2014 Q1 55,096 $5,484,000 +$2,384,868 $99.54 1